The Gross Margin of BridgeBio Pharma Inc (BBIO) is 98.25%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 98.25% |
| 2023-12-31 | 73.71% |
| 2022-12-31 | 95.57% |
| 2021-12-31 | 95.52% |
| 2020-12-31 | 100.00% |
| 2019-12-31 | 93.84% |